Psilocybin for Major Depressive Disorder (MDD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Raison, MD
Usona Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Clinical Research Unit
Birmingham, Alabama, United States
- Preferred Research Partners-Nwa, Llc
Fayetteville, Arkansas, United States
- Preferred Research Partners, Inc.
Little Rock, Arkansas, United States
- Kadima Neuropsychiatry Institute
La Jolla, California, United States
- West la Va Medical Center - Mental Health Department
Los Angeles, California, United States
- Pacific Neuroscience Institute (pni) at Saint John'S Physician Partners
Santa Monica, California, United States
- Psychedelic Science Institute
Santa Monica, California, United States
- Mountain View Clinical Research
Denver, Colorado, United States
- Connecticut Mental Health Center, Yale University
New Haven, Connecticut, United States
- Clinical Neuroscience Solutions Inc.
Jacksonville, Florida, United States
- Innovative Clinical Research, Inc.
Lauderhill, Florida, United States
- Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Cenexel Iresearch, Llc
Decatur, Georgia, United States
- Great Lakes Clinical Trials
Chicago, Illinois, United States
- Johns Hopkins School of Medicine, Center for Psychedelic and Consciousness Research
Baltimore, Maryland, United States
- Sunstone Medical Pc
Rockville, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Va Nebraska Western Iowa Health Care System
Omaha, Nebraska, United States
- Global Medical Institutes, Llc; Princeton Medical Institute
Princeton, New Jersey, United States
- University of New Mexico (unm) Interdisciplinary Substance Use and Brain Injury (isubi) Center
Albuquerque, New Mexico, United States
- Nyu Clinical & Translational Science Institute
New York, New York, United States
- Bronx Veterans Research Foundation at the James J. Peters Vamc
The Bronx, New York, United States
- Aim Trials, Llc
Plano, Texas, United States
- Clinical Trials of Texas, Llc
San Antonio, Texas, United States
- Cedar Clinical Research
Draper, Utah, United States
- Cedar Clinical Research, Inc.
Murray, Utah, United States
- Seattle Neuropsychiatric Treatment Center
Bellevue, Washington, United States
- Va Portland Health Care System
Vancouver, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2024
- Primary completion
- 5 Jan 2026
- Completion
- 30 Jan 2027
- Last update posted
- 1 Jun 2026
- Registered enrollment
- 238
- Registry id
- NCT06308653
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.